Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

TRAVASE

SUTILAINS

Standard Dose
82,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview TRAVASE is listed in Drugs@FDA under application 012828 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient SUTILAINS Form and strength OINTMENT;TOPICAL - 82,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Sponsor ABBOTT Submission history Latest submission status date: 1995-06-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRAVASE is listed in Drugs@FDA under application 012828 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient SUTILAINS Form and strength OINTMENT;TOPICAL - 82,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Sponsor ABBOTT Submission history Latest submission status date: 1995-06-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.